The Motley Fool

3 reasons I’m backing hot stock Versarien plc

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Those with a penchant for small-cap stocks may have noticed the magnificent share price gains of graphene supplier Versarien (LSE: VRS) over the past couple of weeks.

While agreeing with a Foolish colleague that the market minnow still represents a risky purchase, I think the potential rewards on offer make it one worth taking for those with sufficiently long investment time horizons.

5 Stocks For Trying To Build Wealth After 50

Markets around the world are reeling from the coronavirus pandemic… and with so many great companies trading at what look to be ‘discount-bin’ prices, now could be the time for savvy investors to snap up some potential bargains.

But whether you’re a newbie investor or a seasoned pro, deciding which stocks to add to your shopping list can be a daunting prospect during such unprecedented times.

Fortunately, The Motley Fool UK analyst team have short-listed five companies that they believe STILL boast significant long-term growth prospects despite the global upheaval…

We’re sharing the names in a special FREE investing report that you can download today. And if you’re 50 or over, we believe these stocks could be a great fit for any well-diversified portfolio.

Click here to claim your free copy now!

Before looking at my reasons for this, let’s peruse today’s interim numbers. 

“Significant interest”

Group revenues jumped 167% over the six months to the end of September to a little under £4.4m. Although a lack of profit is to be expected at this stage, pre-tax losses at the advanced engineering materials firm almost halved to £770,000 from £1.47m over the same period in 2016. 

Away from the figures, Versarien confirmed that it had seen “significant interest” from original equipment manufacturers (OEMs) for its “few layer graphene non-platelets” (otherwise known as Nanene) over the reporting period. In addition to being awarded two competitive framework tenders to provide its products to the Centre for Process Innovation, Versarien’s Total Carbide business also received its “largest ever order” for parts to be used by “the UK’s largest aero engine manufacturer“.  

As positive as all this sounds, it’s the news since the end of the September that’s really got investors salivating. Arguably the most significant announcements have been those relating to collaborations with Israel Aerospace Industries and a leading global consumer goods company to use Nanene in its packaging. Elsewhere, the establishment of a US sales office in Palo Alto (home of Tesla Motors) “to exploit significant opportunities in the region” is another promising development.

Of course, any one set of results from a company are backward-looking and only a snapshot. To really appreciate the investment case for Versarien, you need to see the bigger picture.

Only the beginning

Although the recently-announced collaborations are a huge lure, it’s what might be revealed over the coming weeks that could really put a rocket under the share price. With the company already hinting at further deals being announced before the end of the year (and November’s £2.8m fundraising now allowing it to scale up Nanene production by a factor of 10), I think those taking a position today could still be handsomely rewarded prior to the market closing for the festive break.  

Another thing I like about Versarien is the fact that CEO Neill Ricketts also happens to be its largest shareholder. When the person running the company has a significant proportion of his own wealth invested, you can be fairly sure that his interests will be aligned with those of its other owners.

My last reason for backing it is perhaps the most important to its success over the long term; namely, the quality of the graphene it produces. While competitors exist, the AIM-listed company is the only one to have had its product independently approved by the University of Manchester — the home of the miracle material. To my mind, that kind of scientific credibility can’t be bought. 

While some share price volatility is perhaps inevitable as traders take profits (and confirmation bias shouldn’t be ignored), the investment case for Versarien is nothing short of compelling, in my view.

Is this little-known company the next ‘Monster’ IPO?

Right now, this ‘screaming BUY’ stock is trading at a steep discount from its IPO price, but it looks like the sky is the limit in the years ahead.

Because this North American company is the clear leader in its field which is estimated to be worth US$261 BILLION by 2025.

The Motley Fool UK analyst team has just published a comprehensive report that shows you exactly why we believe it has so much upside potential.

But I warn you, you’ll need to act quickly, given how fast this ‘Monster IPO’ is already moving.

Click here to see how you can get a copy of this report for yourself today

Paul Summers owns shares in Versarien. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply click below to discover how you can take advantage of this.